Feed CCCC
CC

C4 Therapeutics, Inc.

CCCC · NASDAQ

$2.95 -6.05% (-$0.19)
1M -21.12%
Market Cap $347.2M
P/E Ratio -
Div. Yield -
ROE 45.45%
Analiză

Un raport AI despre afacere, finanțe, evaluare, sentiment, știri și riscuri - scris în câteva minute.

Piotroski F-Score Weak
3/9
Valuation
50 /100
Fair
P/S 9.91x
P/B 1.40x
P/E N/A
Growth
36 /100
Stable
Rev. growth 4.95%
Book val. growth 3.91%
EPS growth N/A
Profitability
20 /100
Weak
Gross margin 94.86%
Net margin 289.44%
Op. margin 318.97%
Quality
1 /100
Poor
ROIC 35.21%
ROE 45.45%
ROA 28.22%
Debt
100 /100
Low
Debt/Equity 0.23x
Current ratio 5.45x
Int. coverage N/A
Stability
25 /100
Unstable
Beta 2.95x
Rev. volatility 53.38%
EPS volatility 22.62%

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre CCCC
Online

Despre companie

C4 Therapeutics, Inc. (CCCC) is a biotechnology company focused on developing novel therapeutics based on protein degradation technology. Their platform enables the creation of small molecules that bind to target proteins and induce their selective degradation. This innovative therapeutic strategy has the potential to treat a wide range of diseases, including cancer and neurodegenerative disorders. C4 Therapeutics collaborates with major pharmaceutical companies to develop and commercialize new drug candidates. Their goal is to bring innovative treatment options to patients with various diseases. Shares of C4 Therapeutics, Inc. (CCCC) may be an attractive investment opportunity for investors interested in advanced therapeutic technologies and the biotechnology sector.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Biotechnology

CEO

Andrew J. Hirsch

Employees

104

Headquarters

Watertown

Evenimente viitoare

05 NOV.

Earnings

Upcoming earnings report

33d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.